TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
161,663
|
104,847
|
91,567 |
Financial expenses |
36
|
8
|
12 |
Earnings before taxes |
6,443
|
4,599
|
2,813 |
EBITDA |
5,996
|
4,492
|
2,834 |
Total assets |
43,942
|
40,204
|
38,354 |
Current assets |
43,919
|
40,171
|
38,308 |
Current liabilities |
28,822
|
27,378
|
28,119 |
Equity capital |
11,476
|
8,949
|
6,851 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
110
|
115
|
106 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.1%
|
22.3%
|
17.9% |
Turnover per employee |
1,470
|
912
|
864 |
Profit as a percentage of turnover |
4.0%
|
4.4%
|
3.1% |
Return on assets (ROA) |
14.7%
|
11.5%
|
7.4% |
Current ratio |
152.4%
|
146.7%
|
136.2% |
Return on equity (ROE) |
56.1%
|
51.4%
|
41.1% |
Change turnover |
56,511
|
20,697
|
-3,139 |
Change turnover % |
54%
|
25%
|
-3% |
Chg. No. of employees |
-5
|
9
|
11 |
Chg. No. of employees % |
-4%
|
8%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.